CapMan sells its holding in Swereco Group

CapMan Press Release - 2.10.2015 at 9.30 a.m. EEST CapMan sells its holding in Swereco Group Funds managed by CapMan have sold their holding in Swereco Group AB, a Swedish manufacturer of OTC products, to Karo Bio AB (publ). The transaction was completed on 1 October 2015. "We are pleased with our investment in Swereco...

New York, 02/10/2015 (informazione.it - comunicati stampa - economia)

CapMan Press Release - 2.10.2015 at 9.30 a.m. EEST

"We are pleased with our investment in Swereco. During our ownership, Swereco has completed several key acquisitions, brought new and interesting products and designs to the OTC market and expanded sales to the other Nordic countries" comments Johan Bennarsten, responsible for the CapMan Life Science IV fund.

Funds managed by CapMan, including the CapMan Life Science IV fund, invested in Swereco AB in 2010 and owned 35.75% of the company's equity prior to the transaction. CapMan Plc is a significant investor in the CapMan Life Science IV fund.

Johan Bennarsten, CapMan Life Science, tel. +46 707 495 659

 

www.capman.com

www.swerecogroup.com

www.karobio.se

Copyright GlobeNewswire


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire